BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zaki S, Blaker CL, Little CB. OA foundations - experimental models of osteoarthritis. Osteoarthritis Cartilage 2021:S1063-4584(21)00884-0. [PMID: 34536528 DOI: 10.1016/j.joca.2021.03.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Little CB, Zaki S, Blaker CL, Clarke EC. Animal models of osteoarthritis: the benefits and costs of reducing variability. Bone & Joint Research 2022;11:514-7. [DOI: 10.1302/2046-3758.118.bjr-2022-0217.r1] [Reference Citation Analysis]
2 Liu Y, Liu J, Ma Y, Zhang Y, Chen Q, Yang X, Shang Y. The protective effects of Olmesartan against interleukin-29 (IL-29)-induced type 2 collagen degradation in human chondrocytes. Bioengineered 2022;13:1802-13. [PMID: 35012432 DOI: 10.1080/21655979.2021.1997090] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Haubruck P, Pinto MM, Moradi B, Little CB, Gentek R. Monocytes, Macrophages, and Their Potential Niches in Synovial Joints - Therapeutic Targets in Post-Traumatic Osteoarthritis? Front Immunol 2021;12:763702. [PMID: 34804052 DOI: 10.3389/fimmu.2021.763702] [Reference Citation Analysis]